The Neuropathic Pain Therapeutics Summit is dedicated to next generation of non-addictive agents for neuropathic pain.
The Neuropathic Pain Therapeutics Summit covers topics such as:
- Biology & Physiology of Neuropathic Pain to Identify Potential Therapeutic Targets & Pathways
- Accelerate Neuropathic Pain Therapeutics to Patients in Need
- Approaches Harnessing the Neuro-Immune Axis to Tackle Neuropathic Pain
- Preclinical Models & Pain Biomarkers to Demonstrate Mechanisms of Action & Objective Quantification of Pain Therapeutics
- Optimizing Medicinal Chemistry, Safety & Efficacy of Ion Channel Modulators to Treat & Manage Neuropathic Pain
- Molecular Approaches in Human Tissues to Identify New Neuropathic Pain Targets
- Gene Therapy Approaches to Treat & Manage Neuropathic Pain
- Novel Small Molecule Approaches for Pain & Peripheral Neuropath
- The Role of Medical Devices Along the Neuropathic Pain Patient Continuum of Care
- Cannabinoid-Based Pharmaceuticals as Therapeutics for Treating & Managing Neuropathic Pain
- The Competitive Landscape to Accelerate the Next Generation of Neuropathic Pain Treatments to Patients in Need
- Collaborative Opportunities for Industry & Academia to Engage in to Advance Neuropathic Pain Drug Development Effort
The Neuropathic Pain Therapeutics Summit brings together attendees from pharma, biotech and academics.
